Part of The Weill Cornell Graduate School of Medical Sciences. A combined program of Weill Cornell Medical College and the Sloan-Kettering Institute, we are a premiere school in biomedical research. We are part of Cornell University (Ithaca, NY) but Weill Cornell Medical College is located in New York City. Read more about our programs of study:
The research activities of the Cornell Pharmacology Program faculty cover broad areas of modern pharmacological sciences. Faculty carry out research in cancer pharmacology, neuropharmacology, cardiovascular pharmacology, drug metabolism, toxicology, proteomics, molecular pharmacology, receptors and signal transduction, and drug design.
March 4, 2014: :
Alissa Brandes (lab of Dr. Yueming Li) received an F31 predoctoral fellowship from The National Institute on Aging. Congratulations, Alissa!
February 27, 2014: :
Drs. Samie Jaffrey and Dilek Colak have uncovered the mechanism for a common form of intellectual disability and autism, and potential drug treatment. Their findings are published in Science. To read the article, click here
January 31, 2014: :
Dr. Mark Lundquist, who received his PhD in Pharmacology last year from our program, Dr. Samie Jaffrey, and their colleagues have identified an important new pathway responsible for the development of cancer and its spread to other parts of the body, a process known as metastasis. The finding provides new opportunities to prevent cancer metastasis and helps to explain how one drug that is already in development works to stop the disease's spread. This work was published in Cell 2014 Jan 30;156(3):563-76.
January 9, 2014: :
The recent Nature Neuroscience paper by Dr. Miklos Toth and colleagues, "Maternal hematopoietic TNF, via milk chemokines, programs hippocampal development and memory" was selected to be highlighted in the Editors' Choice section of Science Signaling, the weekly journal from the publisher of Science magazine. For more, click here.
December 18, 2013: :
Dr. Lonny Levin was featured on NPR in a discussion of the NIH budget. To listen, click Lab Mice Rejoice Over Pending Budget Vote
Stevin Zorn, Ph.D.
Executive Vice President and US Site Head, Neuroscience Research and Development, Lundbeck Research USA
"The Importance of Public/Private Collaboration in Identifying and Validating Targets in Drug Discovery"